Jun 22–25, 2026 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Michael V. Sofroniew, Maria de Lourdes Gamez G Tansey, and Robyn S Klein
-
Scientific Organizers: Michael V. Sofroniew, Maria de Lourdes Gamez G Tansey, and Robyn S Klein
Michael V. Sofroniew
University of California, Los Angeles
Maria de Lourdes Gamez G Tansey, PhD
Maria de Lourdes G Tansey
Robyn S Klein, MD, PhD
Western University, London, Ontario
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandMonday, June 22, 2026
Fundraising
Booking Function
Merchandise Options
Registration Options
Tuesday, June 23, 2026
Modulation of Microglial Function
Genomic Risk for Neuroinflammation
Role of Central-Peripheral Neuroimmune Cross-Talk in Neurodegeneration
Key Inflection Points in Alzheimer’s Disease Pathogenesis
Short Talk: Specificity of CD4 T Cell Response in Parkinson Disease and in a Mouse Model of Synucleinopathy
Short Talk: Unique Progenitor Cells in the APOE3 Christchurch Brain and Their Potential Resilient Roles in Alzheimer’s Disease
Mapping Inflammation in Cerebral Amyloid Angiopathy: AI-Accelerated Spatial Omics Reveals Complement-Driven Vascular Signatures in Alzheimer's Disease
The Interferon-Stimulated Gene Apolipoprotein L6 Demonstrates an Evolutionary Trade-off between Host Defense and Neurodegeneration
Virus-Induced Senescence as a Driver of Neuroinflammation and Brain Aging
Systemic Infection Significantly Impacts the Astrocyte Phenotype in Alzheimer’s Disease
Dissecting Immune Mechanisms by Which Gut Microbes Contribute to Alzheimer’s Disease Using Closely Related Bacterial Strains
Loss of the Alzheimer’s Disease Genetic Risk Factor CASS4 Disrupts Neuroprotective Microglial Responses and Promotes Amyloid Beta-Driven Pathology
Evolution of Neuroimmune Systems
Protection Against Neurotropic Viruses
Host-Pathogen Neuroimmunology Gone Wrong
Short Talk: Astrocytic but not Microglial Antigen Presentation Shapes Protective Immunity to Toxoplasma gondii Neuroinfection
Wednesday, June 24, 2026
Astrocytes and CNS Innate Immunity
Microglia and Neuroinflammation
Inflammation and Anhedonia in Depression: Biomarkers, Mechanisms, and Therapeutic Implications
Microglia, Sex Differences, Neuroinflammation and Psychiatric Disorders
Short Talk: Glial-derived Stress Ligand MULT1, an NKG2D Ligand, Modulates Neuroinflammation in MS Model Through Immune-Glial Cell Crosstalk
Sex-Specific Microglial Transcriptional Programs Promote Synapse Loss and Impaired Cognitive Recovery in Malesafter West Nile Neuroinvasive Disease
Gut Microbiome, Autoimmunity and Neurodegeneration
Microbial Metabolites and Immune Regulation
Stress, Inflammation, Microbiome and Depression
Short Talk: Diet-Induced Activation of Striatal Microglia Contributes to Impairments In Cognitive Control and Flexible Decision-Making
Short Talk: Leptin Directly Modulates Microglia Cytokine Response in the Arcuate Nucleus of the Hypothalamus
Thursday, June 25, 2026
Developing Drugs for CNS Disorders: Considerations for Therapies That Cross the BBB
Human Genetics Identifies Novel Microglial Targeting Therapeutic Approaches for Alzheimer's Disease
Talk Title to be Announced
Selective Targeting of Soluble TNF to Mitigate Neuroinflammation in Neurodegenerative Diseases
Short Talk: Understanding the Chemical and Biological Phenomena That Drive mRNA Lipid Nanoparticle Delivery to the Brain
Short Talk: Beyond the Shuttle: Advances in Brain Delivery of Biologics for the Treatment of Neurodegenerative Diseases
Neurovascular Function and Neuroinflammation
Brain Capillaries, Pericytes, and Neuroinflammation
Short Talk: Vascular Control of NeuroInflammation: A Nanoparticle Based Approach to Probe BBB–Immune Interactions
Innate Immune Receptors in Neuroinflammation
Friday, June 26, 2026
Subscribe for Updates